Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Nutrients ; 13(12)2021 Dec 02.
Artículo en Inglés | MEDLINE | ID: covidwho-1551616

RESUMEN

A single-center, randomized, double-blind, placebo-controlled study was conducted in 72 volunteers who received a synergistic combination of yeast-based ingredients with a unique ß-1,3/1,6-glucan complex and a consortium of heat-treated probiotic Saccharomyces cerevisiae rich in selenium and zinc (ABB C1®) or placebo on the next day after getting vaccinated against influenza (Chiromas®) (n = 34) or the COVID-19 (Comirnaty®) (n = 38). The duration of treatment was 30 and 35 days for the influenza and COVID-19 vaccine groups, respectively. Mean levels of CD4+T cells increased from 910.7 at baseline to 1000.2 cells/µL after the second dose of the COVID-19 vaccine in the ABB C1® group, whereas there was a decrease from 1055.1 to 929.8 cells/µL in the placebo group. Changes of CD3+T and CD8+T lymphocytes showed a similar trend. In the COVID-19 cohort, the increases in both IgG and IgM were higher in the ABB C1® supplement than in the placebo group. Serum levels of selenium and zinc showed a higher increase in subjects treated with the active product than in those receiving placebo. No serious adverse events related to ABB C1® or tolerance issues were reported. The study findings validate the capacity of the ABB C1® product to stimulate trained immunity.


Asunto(s)
Vacunas contra la COVID-19/administración & dosificación , Suplementos Dietéticos , Vacunas contra la Influenza/administración & dosificación , Saccharomyces cerevisiae , Selenio/administración & dosificación , Zinc/administración & dosificación , beta-Glucanos/administración & dosificación , Anticuerpos Antivirales/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Vacunas contra la COVID-19/inmunología , Método Doble Ciego , Femenino , Humanos , Inmunoglobulina G/inmunología , Inmunoglobulina M/inmunología , Vacunas contra la Influenza/inmunología , Masculino , Persona de Mediana Edad , Selenio/inmunología , Zinc/inmunología , beta-Glucanos/inmunología
2.
Nutrients ; 13(10)2021 Sep 25.
Artículo en Inglés | MEDLINE | ID: covidwho-1438686

RESUMEN

Food supplements (FS) are a concentrated source of vitamins, minerals, or other ingredients with nutritional or other physiological effects. Due to their easy availability, widespread advertising, and sometimes low price, increased consumption of this group of preparations has been observed. Therefore, the aim of the study was to assess the knowledge and intake of FS during the COVID-19 pandemic in Poland, with particular reference to FS containing zinc and vitamin D. It was noted that both of the above ingredients were used significantly more often by people with higher education (59.0%), with a medical background or related working in the medical field (54.5%), and/or exercising at home (60.1%). Preparations containing vitamin D were used by 22.8% of the respondents in the first wave, 37.6% in the second wave, and 32.9% in the third wave. To sum up, we showed the highest consumption of vitamin and mineral supplements, and preparations containing zinc and vitamin D were taken significantly more often by people with higher medical and related education. This indicates a high awareness of health aspects and the need for preventive measures in these groups.


Asunto(s)
COVID-19/inmunología , Suplementos Dietéticos/estadística & datos numéricos , Conductas Relacionadas con la Salud , Vitamina D/administración & dosificación , Zinc/administración & dosificación , Adulto , Femenino , Humanos , Masculino , Polonia , SARS-CoV-2 , Oligoelementos/administración & dosificación , Oligoelementos/inmunología , Vitamina D/inmunología , Vitaminas/administración & dosificación , Vitaminas/inmunología , Zinc/inmunología
3.
J Nutr ; 151(7): 1854-1878, 2021 07 01.
Artículo en Inglés | MEDLINE | ID: covidwho-1226546

RESUMEN

BACKGROUND: Many nutrients have powerful immunomodulatory actions with the potential to alter susceptibility to coronavirus disease 2019 (COVID-19) infection, progression to symptoms, likelihood of severe disease, and survival. OBJECTIVE: The aim was to review the latest evidence on how malnutrition across all its forms (under- and overnutrition and micronutrient status) may influence both susceptibility to, and progression of, COVID-19. METHODS: We synthesized information on 13 nutrition-related components and their potential interactions with COVID-19: overweight, obesity, and diabetes; protein-energy malnutrition; anemia; vitamins A, C, D, and E; PUFAs; iron; selenium; zinc; antioxidants; and nutritional support. For each section we provide: 1) a landscape review of pertinent material; 2) a systematic search of the literature in PubMed and EMBASE databases, including a wide range of preprint servers; and 3) a screen of 6 clinical trial registries. All original research was considered, without restriction to study design, and included if it covered: 1) severe acute respiratory syndrome coronavirus (CoV) 2 (SARS-CoV-2), Middle East respiratory syndrome CoV (MERS-CoV), or SARS-CoV viruses and 2) disease susceptibility or 3) disease progression, and 4) the nutritional component of interest. Searches took place between 16 May and 11 August 2020. RESULTS: Across the 13 searches, 2732 articles from PubMed and EMBASE, 4164 articles from the preprint servers, and 433 trials were returned. In the final narrative synthesis, we include 22 published articles, 38 preprint articles, and 79 trials. CONCLUSIONS: Currently there is limited evidence that high-dose supplements of micronutrients will either prevent severe disease or speed up recovery. However, results of clinical trials are eagerly awaited. Given the known impacts of all forms of malnutrition on the immune system, public health strategies to reduce micronutrient deficiencies and undernutrition remain of critical importance. Furthermore, there is strong evidence that prevention of obesity and type 2 diabetes will reduce the risk of serious COVID-19 outcomes. This review is registered at PROSPERO as CRD42020186194.


Asunto(s)
Anemia/epidemiología , COVID-19/epidemiología , COVID-19/inmunología , Diabetes Mellitus/epidemiología , Estado Nutricional , Obesidad/epidemiología , Desnutrición Proteico-Calórica/epidemiología , Antioxidantes/metabolismo , COVID-19/prevención & control , COVID-19/terapia , Comorbilidad , Suplementos Dietéticos , Progresión de la Enfermedad , Ácidos Grasos Omega-3/inmunología , Ácidos Grasos Omega-6/inmunología , Humanos , Hierro/inmunología , Apoyo Nutricional , SARS-CoV-2 , Selenio/inmunología , Índice de Severidad de la Enfermedad , Vitaminas/inmunología , Zinc/inmunología
5.
Maturitas ; 143: 1-9, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: covidwho-696671

RESUMEN

The world is currently in the grips of the coronavirus disease (COVID-19) pandemic, caused by the SARS-CoV-2 virus, which has mutated to allow human-to-human spread. Infection can cause fever, dry cough, fatigue, severe pneumonia, respiratory distress syndrome and in some instances death. COVID-19 affects the immune system by producing a systemic inflammatory response, or cytokine release syndrome. Patients with COVID-19 have shown a high level of pro-inflammatory cytokines and chemokines. There are currently no effective anti-SARS-CoV-2 viral drugs or vaccines. COVID-19 disproportionately affects the elderly, both directly, and through a number of significant age-related comorbidities. Undoubtedly, nutrition is a key determinant of maintaining good health. Key dietary components such as vitamins C, D, E, zinc, selenium and the omega 3 fatty acids have well-established immunomodulatory effects, with benefits in infectious disease. Some of these nutrients have also been shown to have a potential role in the management of COVID-19. In this paper, evidence surrounding the role of these dietary components in immunity as well as their specific effect in COVID-19 patients are discussed. In addition, how supplementation of these nutrients may be used as therapeutic modalities potentially to decrease the morbidity and mortality rates of patients with COVID-19 is discussed.


Asunto(s)
Tratamiento Farmacológico de COVID-19 , COVID-19/inmunología , Vitaminas/uso terapéutico , Ácido Ascórbico/inmunología , Ácido Ascórbico/uso terapéutico , Suplementos Dietéticos , Ácidos Grasos Omega-3/inmunología , Ácidos Grasos Omega-3/uso terapéutico , Humanos , Sistema Inmunológico/efectos de los fármacos , SARS-CoV-2 , Selenio/inmunología , Selenio/uso terapéutico , Vitamina D/inmunología , Vitamina D/uso terapéutico , Vitamina E/inmunología , Vitamina E/uso terapéutico , Vitaminas/inmunología , Zinc/inmunología , Zinc/uso terapéutico
6.
Front Immunol ; 11: 1712, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-690100

RESUMEN

During the current corona pandemic, new therapeutic options against this viral disease are urgently desired. Due to the rapid spread and immense number of affected individuals worldwide, cost-effective, globally available, and safe options with minimal side effects and simple application are extremely warranted. This review will therefore discuss the potential of zinc as preventive and therapeutic agent alone or in combination with other strategies, as zinc meets all the above described criteria. While a variety of data on the association of the individual zinc status with viral and respiratory tract infections are available, study evidence regarding COVID-19 is so far missing but can be assumed as was indicated by others and is detailed in this perspective, focusing on re-balancing of the immune response by zinc supplementation. Especially, the role of zinc in viral-induced vascular complications has barely been discussed, so far. Interestingly, most of the risk groups described for COVID-19 are at the same time groups that were associated with zinc deficiency. As zinc is essential to preserve natural tissue barriers such as the respiratory epithelium, preventing pathogen entry, for a balanced function of the immune system and the redox system, zinc deficiency can probably be added to the factors predisposing individuals to infection and detrimental progression of COVID-19. Finally, due to its direct antiviral properties, it can be assumed that zinc administration is beneficial for most of the population, especially those with suboptimal zinc status.


Asunto(s)
Antivirales/inmunología , Betacoronavirus/fisiología , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/prevención & control , Suplementos Dietéticos , Pandemias/prevención & control , Neumonía Viral/inmunología , Neumonía Viral/prevención & control , Zinc/inmunología , Animales , Antivirales/farmacología , Antivirales/uso terapéutico , COVID-19 , Cilios/efectos de los fármacos , Infecciones por Coronavirus/tratamiento farmacológico , Infecciones por Coronavirus/virología , Homeostasis/inmunología , Humanos , Neumonía Viral/tratamiento farmacológico , Neumonía Viral/virología , Mucosa Respiratoria/inmunología , SARS-CoV-2 , Internalización del Virus/efectos de los fármacos , Replicación Viral/efectos de los fármacos , Zinc/deficiencia , Zinc/farmacología , Zinc/uso terapéutico
8.
Clin Nutr ESPEN ; 38: 65-66, 2020 08.
Artículo en Inglés | MEDLINE | ID: covidwho-625686

RESUMEN

BACKGROUND & AIMS: The COVID-19 infection can lead to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), mainly affecting patients aged 60 and older. Preliminary data suggest that the nutritional status can change the course of the infection, and on the matter, zinc is crucial for growth, development, and the maintenance of immune function. In the absence of treatment for this virus, there is an urgent need to find alternative methods that can contribute to control of disease. The aim of this paper is to establish the relation between zinc and COVID-19. METHODS AND RESULTS: From the prior scientific knowledge, we have performed a review of the literature and examine the role of zinc in immune function in the infection by COVID-19. Our findings are that the zinc as an anti-inflammatory agent may help to optimize immune function and reduce the risk of infection. CONCLUSIONS: Zinc supplementation can be a useful strategy to reduce the global burden of infection in the elderly, there is a need the increased reporting to improve our understanding of COVID-19 and the care of affected patients.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus/tratamiento farmacológico , Inmunidad/efectos de los fármacos , Factores Inmunológicos/administración & dosificación , Neumonía Viral/tratamiento farmacológico , Oligoelementos/administración & dosificación , Zinc/administración & dosificación , Anciano , COVID-19 , Infecciones por Coronavirus/inmunología , Femenino , Humanos , Factores Inmunológicos/inmunología , Masculino , Persona de Mediana Edad , Pandemias , Neumonía Viral/inmunología , SARS-CoV-2 , Oligoelementos/inmunología , Zinc/inmunología , Tratamiento Farmacológico de COVID-19
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA